About Peptobiotics
Peptobiotics is a company based in Singapore (Singapore) founded in 2021. Peptobiotics has raised $6.2 million across 1 funding round from investors including The Trendlines Group, Hatch Blue and GrainCorp. Peptobiotics operates in a competitive market with competitors including Proteon Pharmaceuticals, NovoBind Livestock Therapeutics, Carus Laboratories, Anifera and Ponni Symbiologicals, among others.
- Headquarter Singapore, Singapore
-
Sectors
Agriculture
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vaciome Pte. Ltd.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$6.2 M (USD)
in 1 rounds
-
Latest Funding Round
$6.2 M (USD), Series A
Apr 09, 2024
-
Investors
The Trendlines Group
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Peptobiotics
Peptobiotics has successfully raised a total of $6.2M through 1 strategic funding round. The most recent funding activity was a Series A round of $6.2 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $6.2M
-
First Round
First Round
(09 Apr 2024)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2024 | Amount | Series A - Peptobiotics | Valuation | Hatch Blue |
Investors in Peptobiotics
Peptobiotics has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include The Trendlines Group, Hatch Blue and GrainCorp.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund and startup incubator for healthcare and agricultural companies
|
Founded Year | Domain | Location | |
|
VC funding and acceleration services for agtech startups are provided.
|
Founded Year | Domain | Location | |
|
Government-backed fund investing in tech startups
|
Founded Year | Domain | Location |
Investments & Acquisitions by Peptobiotics
Financial Statements - Peptobiotics
Peptobiotics Comparisons
Competitors of Peptobiotics
Peptobiotics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Proteon Pharmaceuticals, NovoBind Livestock Therapeutics, Carus Laboratories, Anifera and Ponni Symbiologicals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for animal infectious diseases are developed via phage platforms.
|
|
| domain | founded_year | HQ Location |
Manufacturer and supplier of biological products for animal health protection
|
|
| domain | founded_year | HQ Location |
Provides comprehensive solutions for veterinary feed supplements.
|
|
| domain | founded_year | HQ Location |
Antibiotic detection and control solutions for livestock are provided.
|
|
| domain | founded_year | HQ Location |
Provides pharmaceutical products tailored for poultry farmers.
|
Frequently Asked Questions about Peptobiotics
Peptobiotics was founded in 2021 and raised its 1st funding round 3 years after it was founded.
Peptobiotics is headquartered in Singapore, Singapore.
Peptobiotics is a funded company, having raised a total of $6.2M across 1 funding round to date. The company's 1st funding round was a Series A of $6.2M, raised on Apr 09, 2024.
Peptobiotics was established in 2021 in Singapore. Focus is placed on the production of peptides-based additives for livestock feed within the agriculture sector. Operations involve the development and manufacturing of these supplements to support animal health and growth. The companys activities are centered in Singapore, with its online presence maintained through the domain peptobiotics.com. Services target the global livestock industry, emphasizing sustainable feed solutions.
Peptobiotics's top competitors include Proteon Pharmaceuticals, NovoBind Livestock Therapeutics and Anifera.
Peptobiotics has 8 investors. Key investors include The Trendlines Group, Hatch Blue, GrainCorp, Farmabase, and Ponderosa Ventures.